Double-blind, Randomized Study of Extended-release Quetiapine Fumarate (Seroquel XR) in the Treatment of Patients with Comorbid Depression and Anxiety Disorder
ID Number 09-0807Principal Investigator(s)
Department(s) or Division(s)
The purpose of this study is to see if the addition of Seroquel-XR to cognitive behavioral therapy improves depressive and anxiety symptoms faster and with a better resolution that therapy alone.
Recruiting Patients: Yes